Form 4 for TWST Twist Bioscience Corp
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0001214659-21-012739 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-06 | 2021-12-02 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $26.20 | +1,758 | 40.0K | +5% | +$46.1K |
| DM | 2021-12-06 | 2021-12-02 | TWST | Finn Patrick John | Chief Commercial Off | S - Sale+OE | $88.04 | -1,758 | 38.8K | -4% | -$154.8K |
| DM | 2021-12-06 | 2021-12-02 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $0.00 | -1,758 | 20.2K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | M | A | 1,517 | $26.66 | 39,751 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-02 | S | D | 586 | $90.00 | 38,234 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-02 | S | D | 1,172 | $87.06 | 38,820 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-02 | M | A | 241 | $23.33 | 39,992 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-12-02 | M | D | 1,517 | $0.00 | 34,891 | D | $26.66 · — to 2028-11-18 | 1,517 Common Stock | (F2) 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-12-02 | M | D | 241 | $0.00 | 20,204 | D | $23.33 · — to 2029-10-23 | 241 Common Stock | (F3) 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |